Literature DB >> 16489037

Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium.

Jiahua Tan1, Ling Geng, Eugenia M Yazlovitskaya, Dennis E Hallahan.   

Abstract

The vascular endothelium plays a critical role in the response of cancer to ionizing radiation. Activation of the phosphoinositide-3-kinase/Akt pathway is one initial signaling event in irradiated endothelial cells. Specifically, a low dose of ionizing radiation (3 Gy) induces phosphorylation of Akt at Ser473 in the vascular endothelium within minutes of irradiation. However, signaling events that are downstream of Akt have not been well defined. Here, we show that phosphorylation of the Akt downstream target glycogen synthase kinase-3beta (GSK-3beta) at Ser9 also occurred within minutes of exposure to ionizing radiation. In addition, ionizing radiation caused the dissociation of GSK-3beta from the cell membrane, consistent with the inactivation of GSK-3beta enzyme activity. Overexpression of the dominant negative mutant Akt attenuated GSK-3beta phosphorylation at Ser9 and enhanced radiation-induced apoptosis. X-irradiated endothelial cells formed capillaries in both in vitro and in vivo models, whereas overexpression of the dominant negative mutant Akt inhibited capillary tubule formation. Studies using GSK-3beta antagonists showed that GSK-3beta activity was required for apoptosis in endothelial cells treated simultaneously with Akt antagonists and radiation. In mouse vascular models, radiation-induced microvascular destruction in response to Akt antagonists also required GSK-3beta function. These data indicate that on exposure of vascular endothelium to ionizing radiation, activation of Akt signaling contributes to GSK-3beta inhibition, which in turn promotes endothelial cell survival and capillary formation. Thus, pharmacologic regulation of Akt/GSK-3beta signaling may present a new approach to the radiation response in the tumor microvasculature.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16489037     DOI: 10.1158/0008-5472.CAN-05-2700

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer.

Authors:  Richard L Watson; Aaron C Spalding; Steven P Zielske; Meredith Morgan; Alex C Kim; Guido T Bommer; Hagit Eldar-Finkelman; Thomas Giordano; Eric R Fearon; Gary D Hammer; Theodore S Lawrence; Edgar Ben-Josef
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

Review 2.  The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways.

Authors:  Eléonore Beurel; Richard S Jope
Journal:  Prog Neurobiol       Date:  2006-08-28       Impact factor: 11.685

Review 3.  New advances that enable identification of glioblastoma recurrence.

Authors:  Isaac Yang; Manish K Aghi
Journal:  Nat Rev Clin Oncol       Date:  2009-10-06       Impact factor: 66.675

4.  The laminin binding α3 and α6 integrins cooperate to promote epithelial cell adhesion and growth.

Authors:  Eugenia M Yazlovitskaya; Olga M Viquez; Tianxiang Tu; Adele De Arcangelis; Elisabeth Georges-Labouesse; Arnoud Sonnenberg; Ambra Pozzi; Roy Zent
Journal:  Matrix Biol       Date:  2018-09-04       Impact factor: 11.583

Review 5.  Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy.

Authors:  Jeffrey M Craft; Dennis Hallahan
Journal:  Future Med Chem       Date:  2011-05       Impact factor: 3.808

6.  Extracellular adenosine enhances pulmonary artery vasa vasorum endothelial cell barrier function via Gi/ELMO1/Rac1/PKA-dependent signaling mechanisms.

Authors:  Alexander D Verin; Robert Batori; Anita Kovacs-Kasa; Mary Cherian-Shaw; Sanjiv Kumar; Istvan Czikora; Vijaya Karoor; Derek Strassheim; Kurt R Stenmark; Evgenia V Gerasimovskaya
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-20       Impact factor: 4.249

7.  Nuclear accumulation of cyclin D1 following long-term fractionated exposures to low-dose ionizing radiation in normal human diploid cells.

Authors:  Tsutomu Shimura; Nobuyuki Hamada; Megumi Sasatani; Kenji Kamiya; Naoki Kunugita
Journal:  Cell Cycle       Date:  2014-02-14       Impact factor: 4.534

8.  Enzastaurin (LY317615), a protein kinase C beta selective inhibitor, enhances antiangiogenic effect of radiation.

Authors:  Christopher D Willey; Dakai Xiao; Tianxiang Tu; Kwang Woon Kim; Luigi Moretti; Kenneth J Niermann; Mohammed N Tawtawy; Chad C Quarles; Bo Lu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-10       Impact factor: 7.038

9.  Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma.

Authors:  Oleksandr Ekshyyan; Youhua Rong; Xiaohua Rong; Kavita M Pattani; Fleurette Abreo; Gloria Caldito; John Kai Siung Chang; Federico Ampil; Jonathan Glass; Cherie-Ann O Nathan
Journal:  Mol Cancer Ther       Date:  2009-07-22       Impact factor: 6.261

10.  Enzastaurin, an inhibitor of PKCbeta, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial Cells.

Authors:  Aaron C Spalding; Benjamin D Zeitlin; Kari Wilder-Romans; Mary E Davis; Jacques E Nor; Theodore S Lawrence; Edgar Ben-Josef
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.